PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
0.92%
Positive revenue growth while 3141.T is negative. John Neff might see a notable competitive edge here.
3.15%
Positive gross profit growth while 3141.T is negative. John Neff would see a clear operational edge over the competitor.
32.84%
Positive EBIT growth while 3141.T is negative. John Neff might see a substantial edge in operational management.
28.75%
Positive operating income growth while 3141.T is negative. John Neff might view this as a competitive edge in operations.
25.93%
Positive net income growth while 3141.T is negative. John Neff might see a big relative performance advantage.
25.93%
Positive EPS growth while 3141.T is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
25.93%
Positive diluted EPS growth while 3141.T is negative. John Neff might view this as a strong relative advantage in controlling dilution.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
142.00%
10Y revenue/share CAGR at 50-75% of 3141.T's 190.52%. Martin Whitman would question if the firm’s offerings lag behind the competitor.
46.86%
5Y revenue/share CAGR similar to 3141.T's 51.29%. Walter Schloss might see both companies benefiting from the same mid-term trends.
31.11%
3Y revenue/share CAGR similar to 3141.T's 29.95%. Walter Schloss would assume both companies experience comparable short-term cycles.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
182.37%
Net income/share CAGR above 1.5x 3141.T's 53.96% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
44.64%
Positive 5Y CAGR while 3141.T is negative. John Neff might view this as a strong mid-term relative advantage.
51.81%
Positive short-term CAGR while 3141.T is negative. John Neff would see a clear advantage in near-term profit trajectory.
304.14%
10Y equity/share CAGR above 1.5x 3141.T's 191.91%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
79.56%
5Y equity/share CAGR 1.25-1.5x 3141.T's 60.57%. Bruce Berkowitz confirms if reinvested profits or buybacks explain the superior buildup.
35.29%
3Y equity/share CAGR 1.25-1.5x 3141.T's 27.13%. Bruce Berkowitz confirms timely buybacks or margin improvements drive stronger near-term equity growth.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
62.50%
Our short-term dividend growth is positive while 3141.T cut theirs. John Neff views it as a comparative advantage in shareholder returns.
-1.61%
Firm’s AR is declining while 3141.T shows 1.66%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-6.17%
Inventory is declining while 3141.T stands at 12.19%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-2.56%
Negative asset growth while 3141.T invests at 1.77%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
2.19%
Positive BV/share change while 3141.T is negative. John Neff sees a clear edge over a competitor losing equity.
11.12%
Debt growth far above 3141.T's 6.57%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
-1.84%
We cut SG&A while 3141.T invests at 4.73%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.